This antidepressant may keep COVID-19 patients out of hospital
November 30, 2020
An anxiety-fighting drug that has been on the market for decades could turn out to be a potent weapon in the fight against COVID-19.
Early-stage research published in a major journal this month found the antidepressant fluvoxamine may prevent patients with COVID-19 from needing hospital care.
The findings are strong, but preliminary. According to a report in JAMA, no one who took the drug for two weeks soon after being diagnosed with COVID developed serious breathing problems, vs. 8% on a placebo who had shortness of breath and low oxygen levels. The study involved 152 people.